208 related articles for article (PubMed ID: 28087879)
1. Management of Daily Glycemic Fluctuations in Patients With Type 2 Diabetes.
Kushner PR
J Fam Pract; 2016 Nov; 65(11 Suppl):. PubMed ID: 28087879
[TBL] [Abstract][Full Text] [Related]
2. Women with Type 2 Diabetes and Glycemic Control.
Gosse S
Medsurg Nurs; 2014; 23(5):317-20, 329. PubMed ID: 26292437
[TBL] [Abstract][Full Text] [Related]
3. Improved Glycemic Control With Minimal Change in Medication Regimen Complexity in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
Morello CM; Rotunno T; Khoan J; Hirsch JD
Ann Pharmacother; 2018 Nov; 52(11):1091-1097. PubMed ID: 29775079
[TBL] [Abstract][Full Text] [Related]
4. Results of a Study Comparing Glycated Albumin to Other Glycemic Indices.
Desouza CV; Holcomb RG; Rosenstock J; Frias JP; Hsia SH; Klein EJ; Zhou R; Kohzuma T; Fonseca VA
J Clin Endocrinol Metab; 2020 Mar; 105(3):677-87. PubMed ID: 31650161
[TBL] [Abstract][Full Text] [Related]
5. Glycemic relapse in type 2 diabetes.
Graber AL; Shintani AK; Wolff K; Brown A; Elasy TA
Endocr Pract; 2006; 12(2):145-51. PubMed ID: 16690461
[TBL] [Abstract][Full Text] [Related]
6. GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS.
Desouza CV; Rosenstock J; Zhou R; Holcomb RG; Fonseca VA
Endocr Pract; 2015 Nov; 21(11):1195-203. PubMed ID: 26214108
[TBL] [Abstract][Full Text] [Related]
7. Association of Potentially Modifiable Diabetes Care Factors With Glycemic Control in Patients With Insulin-Treated Type 2 Diabetes.
Lauffenburger JC; Lewey J; Jan S; Lee J; Ghazinouri R; Choudhry NK
JAMA Netw Open; 2020 Jan; 3(1):e1919645. PubMed ID: 31968115
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update.
; Lipscombe L; Butalia S; Dasgupta K; Eurich DT; MacCallum L; Shah BR; Simpson S; Senior PA
Can J Diabetes; 2020 Oct; 44(7):575-591. PubMed ID: 32972640
[No Abstract] [Full Text] [Related]
9. A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes.
Anjana RM; Kesavadev J; Neeta D; Tiwaskar M; Pradeepa R; Jebarani S; Thangamani S; Sastry NG; Brijendra Kumar S; Ramu M; Gupta PPK; Vignesh J; Chandru S; Kayalvizhi S; Jagdish PS; Uthra SCB; Lovelena M; Jyoti S; Suguna Priya S; Kannan A; Mohan V; Unnikrishnan R
Diabetes Technol Ther; 2017 Sep; 19(9):533-540. PubMed ID: 28930495
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update - The User's Guide.
; Senior PA; Houlden RL; Kim J; Mackay D; Nagpal S; Rabi D; Sherifali D; Bajaj HS
Can J Diabetes; 2020 Oct; 44(7):592-596. PubMed ID: 32972641
[No Abstract] [Full Text] [Related]
11. Nateglinide and acarbose are comparably effective reducers of postprandial glycemic excursions in chinese antihyperglycemic agent-naive subjects with type 2 diabetes.
Zhou J; Li H; Zhang X; Peng Y; Mo Y; Bao Y; Jia W
Diabetes Technol Ther; 2013 Jun; 15(6):481-8. PubMed ID: 23631607
[TBL] [Abstract][Full Text] [Related]
12. Moving beyond HbA1c and plasma glucose levels to understand glycemic status in type 2 diabetes mellitus.
Vijayakumar V; Mavathur R; Aruchunan M; Nandi Krishnamurthy M
J Diabetes; 2018 Jul; 10(7):609-610. PubMed ID: 29437298
[No Abstract] [Full Text] [Related]
13. Glycemic response to newly initiated diabetes therapies.
Karter AJ; Moffet HH; Liu J; Parker MM; Ahmed AT; Go AS; Selby JV
Am J Manag Care; 2007 Nov; 13(11):598-606. PubMed ID: 17988185
[TBL] [Abstract][Full Text] [Related]
14. Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation.
Kesavadev J; Vigersky R; Shin J; Pillai PBS; Shankar A; Sanal G; Krishnan G; Jothydev S
Adv Ther; 2017 Aug; 34(8):1918-1927. PubMed ID: 28667580
[TBL] [Abstract][Full Text] [Related]
15. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
Kennedy L; Herman WH; Strange P; Harris A;
Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
[TBL] [Abstract][Full Text] [Related]
16. Optimizing Insulin Therapy: Basal Insulin and Beyond.
Aroda V; Johnson EL; Novak L; Skolnik N
J Fam Pract; 2018 Oct; 67(10 Suppl):. PubMed ID: 30423012
[TBL] [Abstract][Full Text] [Related]
17. [Compliance to treatment and type 2 diabetes: impact on glycemic balance].
Guillausseau PJ
Presse Med; 2003 Jan; 32(2):70. PubMed ID: 12653029
[No Abstract] [Full Text] [Related]
18. The Influence of Proton-Pump Inhibitors on Glycemic Control: A Systematic Review of the Literature and a Meta-Analysis.
Gómez-Izquierdo JC; Yu OHY
Can J Diabetes; 2017 Aug; 41(4):351-361. PubMed ID: 28373033
[TBL] [Abstract][Full Text] [Related]
19. Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis.
Ushigome E; Matsusaki S; Watanabe N; Hashimoto T; Nakamura N; Fukui M
J Diabetes Investig; 2020 Nov; 11(6):1570-1574. PubMed ID: 32356596
[TBL] [Abstract][Full Text] [Related]
20. Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: A population-based observational study.
Ke C; Stukel TA; Shah BR; Lau E; Ma RC; So WY; Kong AP; Chow E; Chan JCN; Luk A
PLoS Med; 2020 Sep; 17(9):e1003316. PubMed ID: 32946450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
